NCT03945123

Brief Summary

Korea Red Ginseng (KRG) has effect on liver function

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2018

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 3, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 10, 2019

Completed
Last Updated

May 10, 2019

Status Verified

May 1, 2019

Enrollment Period

12 months

First QC Date

May 3, 2019

Last Update Submit

May 7, 2019

Conditions

Liver Dysfunction

Keywords

ginsengLiver

Outcome Measures

Primary Outcomes (1)

  • Liver enzyme

    Decrease liver enzyme level

    1year

Study Arms (1)

Ginseng trial

EXPERIMENTAL

compare experimental group to controlled group

Dietary Supplement: Red ginseng

Interventions

Red ginsengDIETARY_SUPPLEMENT

Red ginseng tablet 120g

Also known as: Red ginseng tablet
Ginseng trial

Eligibility Criteria

Age37 Years - 63 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • AST or ALT level \> 50 IU/L

You may not qualify if:

  • Viral hepatitis
  • Alcoholic hepatitis
  • Autoimmune hepatitis
  • Pancreatitis
  • Hemochromatosis
  • Wilson's disease
  • Drug induced liver injury
  • Cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ChuncheonSHH

Chuncheon, Gangwon-do, South Korea

Location

Related Publications (1)

  • Hong JT, Lee MJ, Yoon SJ, Shin SP, Bang CS, Baik GH, Kim DJ, Youn GS, Shin MJ, Ham YL, Suk KT, Kim BS. Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. J Ginseng Res. 2021 Mar;45(2):316-324. doi: 10.1016/j.jgr.2020.07.004. Epub 2020 Jul 16.

    PMID: 33841012DERIVED

MeSH Terms

Conditions

Liver Diseases

Interventions

Asian ginseng

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Ki Tae Suk, PhD.Md.

    Chuncheon Sacred Heart Hospital

    STUDY CHAIR

  • Jun Seok, MD.

    Chuncheon Sacred Heart Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Proffesor

Study Record Dates

First Submitted

May 3, 2019

First Posted

May 10, 2019

Study Start

January 1, 2018

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

May 10, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Not yet

Locations

KR(1)